Vasomotor symptoms in menopause: physiologic condition and central nervous system approaches to treatment

被引:69
作者
Rapkin, Andrea J. [1 ]
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Obstet & Gynecol, Los Angeles, CA 90095 USA
关键词
menopause; selective serotonin reuptake inhibitor; serotonin-norepinephrine reuptake inhibitor; vasomotor symptoms;
D O I
10.1016/j.ajog.2006.05.056
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: The decline in concentrations of gonadal hormones during menopause gives rise to a range of physiologic and psychologic changes that may impact a woman's health and quality of life significantly. Most notable among these are vasomotor symptoms (hot flashes and night sweats) and mood and sleep disturbances. STUDY DESIGN: This article reviews the physiologic condition underlying menopausal vasomotor symptoms and centrally active, nonhormonal therapies that have demonstrated efficacy for their treatment. RESULTS: Despite the emergence of a range of nonhormonal treatments for vasomotor symptoms, a need still exists for safe and effective therapeutic options that directly target the underlying thermoregulatory mechanisms for women who want treatment but prefer to avoid hormone therapy or for whom hormone therapy is contraindicated. CONCLUSION: The availability of centrally active therapies for menopausal vasomotor symptoms with risks and benefits clearly defined by results from well-designed clinical trials has the potential to allay safety concerns that are associated with the treatment of these common symptoms.
引用
收藏
页码:97 / 106
页数:10
相关论文
共 96 条
[11]   STUDY OF EFFECTIVENESS OF PROPRANOLOL IN MENOPAUSAL HOT FLUSHES [J].
COOPE, J ;
WILLIAMS, S ;
PATTERSON, JS .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1978, 85 (06) :472-475
[12]   MEASURING THE IMPACT OF MENOPAUSAL SYMPTOMS ON QUALITY-OF-LIFE [J].
DALY, E ;
GRAY, A ;
BARLOW, D ;
MCPHERSON, K ;
ROCHE, M ;
VESSEY, M .
BRITISH MEDICAL JOURNAL, 1993, 307 (6908) :836-840
[13]   VERALIPRIDE - ALTERNATIVE ANTIDOPAMINERGIC TREATMENT FOR MENOPAUSAL SYMPTOMS [J].
DAVID, A ;
DON, R ;
TAJCHNER, G ;
WEISSGLAS, L .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1988, 158 (05) :1107-1115
[14]  
DEECHER DC, DESVENLAFAXINE ALLEV
[15]   A prospective population-based study of menopausal symptoms [J].
Dennerstein, L ;
Dudley, EC ;
Hopper, JL ;
Guthrie, JR ;
Burger, HG .
OBSTETRICS AND GYNECOLOGY, 2000, 96 (03) :351-358
[16]   Management of postmenopausal hot flushes with venlafaxine hydrochloride: A randomized, controlled trial [J].
Evans, ML ;
Pritts, E ;
Vittinghoff, E ;
McClish, K ;
Morgan, KS ;
Jaffe, RB .
OBSTETRICS AND GYNECOLOGY, 2005, 105 (01) :161-166
[17]   THE PREVALENCE OF HOT FLASH AND ASSOCIATED VARIABLES AMONG PERIMENOPAUSAL WOMEN [J].
FELDMAN, BM ;
VODA, A ;
GRONSETH, E .
RESEARCH IN NURSING & HEALTH, 1985, 8 (03) :261-268
[18]   Pathophysiology and treatment of menopausal hot flashes [J].
Freedman, RR .
SEMINARS IN REPRODUCTIVE MEDICINE, 2005, 23 (02) :117-125
[19]   Lack of sleep disturbance from menopausal hot flashes [J].
Freedman, RR ;
Roehrs, TA .
FERTILITY AND STERILITY, 2004, 82 (01) :138-144
[20]   Biochemical, metabolic, and vascular mechanisms in menopausal hot flashes [J].
Freedman, RR .
FERTILITY AND STERILITY, 1998, 70 (02) :332-337